News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Session R.A. II
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/14/2023 |
4
| Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Sold 80,528 shares
@ $0.7082, valued at
$57k
Sold 5,344 shares
@ $0.7, valued at
$3.7k
|
|
03/08/2023 |
4
| Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Acquired 251,296 shares
@ $0 Disposed/sold 199,500 options to buy
@ $1.95, valued at
$389k
|
|
12/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2022 |
4
| Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 217,850 options to buy
@ $5.96, valued at
$1.3M
|
|
12/08/2021 |
4
| Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Bought 16,510 shares
@ $12.12, valued at
$200.1k
Bought 26,008 shares
@ $12.65, valued at
$329k
|
|
01/20/2021 |
4
| Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.
Txns:
| Granted 199,700 options to buy
@ $31, valued at
$6.2M
|
|
10/05/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
09/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/27/2020 |
3
| Session R.A. II (Director) has filed a Form 3 on Chardan Healthcare Acquisition 2 Corp. |
05/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2018 |
4
| Session R.A. II (Sr. VP, Corp Strategy) has filed a Form 4 on AveXis, Inc.
Txns:
| Granted 1,667 shares
@ $0 Granted 6,572 options to buy
@ $133.8, valued at
$879.3k
|
|
05/12/2017 |
4
| Session R.A. II (Sr. VP, Corp Strategy) has filed a Form 4 on AveXis, Inc.
Txns:
| Granted 1,282 options to buy
@ $77.24, valued at
$99k
|
|
03/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/23/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|